This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H et al. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 2000; 14: 1743–1750.
Liu J, Miller DS, Saavedra JE, Keefer LK, Johnson DR, Klaassesn CD et al. Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol 2001; 60: 302–309.
Vernhet L, Seite M-P, Allain N, Guillouzo A, Fardel O . Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes. J Pharm Exp Ther 2001; 298: 234–239.
Lorico A, Bertola A, Baum C, Fodstad O, Rappa G . Role of the multidrug resistance protein 1 in protection from heavy metal oxyanions: investigations in vitro and MRP1-deficient mice. Biochem Biophys Res Commun 2002; 291: 617–622.
Takeshita A, Shinjo K, Naito K, Ohnishi K, Sugimoto Y, Yamakawa Y et al. Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA. Br J Haematol 2000; 108: 90–92.
Matsui H, Takeshita A, Naito K, Shinjo K, Shigeno K, Maekawa M et al. Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug-resistance modifiers. Leukemia 2002; 16: 813–819.
Perkins C, Kim CN, Fang G, Bhalla N . Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-abl or overexpress MDR, MRP, Bcl-2, or Bcl-xL. Blood 2000; 95: 1014–1022.
Lehmann S, Bengtzen S, Paul A, Christensson B, Paul C . Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance. Eur J Haematol 2001; 66: 357–364.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takeshita, A., Shinjo, K., Naito, K. et al. P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As2O3), but are not the main mechanism of As2O3-resistance in acute promyelocytic leukemia cells. Leukemia 17, 648–650 (2003). https://doi.org/10.1038/sj.leu.2402851
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402851
This article is cited by
-
Metabolism of arsenic in human liver: the role of membrane transporters
Archives of Toxicology (2010)
-
Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells
Leukemia (2005)